Keywords: european, launches, bi, tnf, cancer, drug, corrected

European launches for BI's TNF cancer drug - corrected story

Article | 16 September 1999

Boehringer Ingelheim has launched its tumor necrosis factor-alpha 1aBeromun (tasonermin) in certain European countries for the treatment of soft tissue ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Boehringer Ingelheim

Go to company listing

Related Drugs

Alkeran

melphalan

Alpha

Prolastin

Go to drug listing